| Net income | -109.77M |
| Less: income from discontinued operations | |
| Less: gain on disposal of discontinued operations | |
| Income from continuing operations | |
| Depreciation | 48.44M |
| Amortization | 46.28M |
| Stock-based compensation | 23.01M |
| Provision for excess and obsolete inventory | 15.15M |
| Tax benefit related to stock options and restricted stock units | |
| Other | 151K |
| Accounts receivable | 45.66M |
| Inventories | 48.6M |
| Prepayments and other assets | |
| Deferred revenue and customer advances | |
| Accounts payable and accrued expenses | -47.94M |
| Retirement plan contributions | -5.87M |
| Accrued income taxes | |
| Net cash provided by operating activities from continuing operations | 408.74M |
| Net cash (used for) provided by operating activities from discontinued operations | |
| Net cash provided by operating activities | |
| Purchases of property, plant and equipment | -66.25M |
| Purchases of available-for-sale marketable securities | -875.84M |
| Proceeds from sales and maturities of available-for-sale marketable securities | 466.74M |
| Proceeds from sales of trading marketable securities | |
| Proceeds from life insurance | |
| Net cash used for investing activities from continuing operations | -268.13M |
| Net cash provided by investing activities from discontinued operations | |
| Net cash used for investing activities | |
| Issuance of common stock under employee stock option and stock purchase plans | 20.09M |
| Tax benefit related to stock options and restricted stock units | 3.4M |
| Payments of long-term debt | |
| Net cash provided by financing activities | |
| Increase (decrease) in cash and cash equivalents | 33.23M |
| Cash and cash equivalents at beginning of period | 264.71M |
| Cash and cash equivalents at end of period | 297.94M |